OPTIRAY 160 Drug Patent Profile
✉ Email this page to a colleague
When do Optiray 160 patents expire, and what generic alternatives are available?
Optiray 160 is a drug marketed by Liebel-flarsheim and is included in one NDA.
The generic ingredient in OPTIRAY 160 is ioversol. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ioversol profile page.
Summary for OPTIRAY 160
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 3 |
Patent Applications: | 2,047 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OPTIRAY 160 at DailyMed |
Recent Clinical Trials for OPTIRAY 160
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Duke Clinical Research Institute | Phase 4 |
GE Healthcare | Phase 4 |
Bayer | Phase 4 |
Pharmacology for OPTIRAY 160
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for OPTIRAY 160
US Patents and Regulatory Information for OPTIRAY 160
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liebel-flarsheim | OPTIRAY 160 | ioversol | INJECTABLE;INJECTION | 019710-003 | Dec 30, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OPTIRAY 160
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Liebel-flarsheim | OPTIRAY 160 | ioversol | INJECTABLE;INJECTION | 019710-003 | Dec 30, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OPTIRAY 160
See the table below for patents covering OPTIRAY 160 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 9151182 | ⤷ Try a Trial | |
Germany | 3362967 | ⤷ Try a Trial | |
European Patent Office | 0083964 | COMPOUNDS SUITABLE FOR X-RAY VISUALISATION METHODS | ⤷ Try a Trial |
Japan | S58131970 | COMPOUND | ⤷ Try a Trial |
Australia | 552188 | ⤷ Try a Trial | |
Netherlands | 930067 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OPTIRAY 160
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0083964 | 93C0142 | Belgium | ⤷ Try a Trial | PRODUCT NAME: IOVERSOL; NAT. REGISTRATION NO/DATE: 74 IS 56 F12/19910521; FIRST REGISTRATION: NL RVG 13345 19891016 |
0083964 | SPC/GB93/089 | United Kingdom | ⤷ Try a Trial | SPC/GB93/089: 20041015 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |